Stockhead on MSN7mon
LTP enters deal with Aptar Pharma to develop Spontan nasal sprayLTR Pharma and Aptar Pharma have entered into a co-development agreement for Spontan The primary goal is commercialisation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback